已发表论文

药师主导的抗感染会诊对治疗结果的影响:一家三级医院的回顾性队列研究

 

Authors Xin C, Zheng B, Zhao Q, Yang W , Feng P, Tu Y

Received 15 April 2025

Accepted for publication 1 July 2025

Published 28 July 2025 Volume 2025:18 Pages 3735—3744

DOI https://doi.org/10.2147/IDR.S534678

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Prof. Dr. Héctor M. Mora-Montes

Chuanwei Xin,1 Bei Zheng,1 Qinqin Zhao,1 Wenjuan Yang,1 Pinpin Feng,1 Yuexing Tu2 

1Department of Pharmacy, Tongde Hospital of Zhejiang Province, Hangzhou, People’s Republic of China; 2Department of Critical Care Medicine, Tongde Hospital of Zhejiang Province, Hangzhou, People’s Republic of China

Correspondence: Yuexing Tu, Department of Critical Care Medicine, Tongde Hospital of Zhejiang Province, No. 234 Gucui Road, Xihu District, Hangzhou, Zhejiang Province, 310012, People’s Republic of China, Email tuyuexing1988@163.com

Objective: To evaluate the clinical and economic impact of pharmacist-led anti-infective consultations in a Chinese tertiary hospital under diagnosis-related group (DRG) payment reforms.
Methods: This retrospective cohort study analyzed inpatients receiving pharmacist-led anti-infective consultations from Tongde Hospital of Zhejiang Province in 2024. Patients were stratified into adherence and non-adherence groups based on clinicians’ implementation of pharmacist recommendations. Outcomes included clinical response rates, adverse drug reactions (ADRs), 14-day mortality, total costs of antimicrobial therapy and total hospitalization costs.
Results: In this study, clinical pharmacists conducted 498 anti-infective therapy consultations for 313 patients, with 82.13% (409/498) of their recommendations being accepted by clinicians. The results demonstrated that adherence to clinical pharmacist recommendations significantly enhanced the clinical response rate (81.99% vs 38.46%, p < 0.05), decreased the incidence of adverse drug reactions (4.21% vs 13.46%, p< 0.05), and reduced 14-day mortality (5.75% vs 17.31%, p< 0.05). Furthermore, adherence led to a 69% reduction in the average cost of antimicrobial therapy ($1830.79 vs $5983.14, p< 0.05) and a 58% decrease in the average total cost of hospitalization ($15,306.17 vs $36,799.11, p< 0.05).
Conclusion: Pharmacist-led anti-infective consultations demonstrate efficacy in enhancing infection treatment outcomes and curbing antimicrobial expenditures, providing actionable evidence for scaling antimicrobial stewardship programs in one DRG-based hospital in China.

Keywords: pharmacist-led consultations, anti-infective, therapeutic outcomes